iCAD is a medical technology company providing cancer detection and therapy solutions. The company has two segments: Cancer Detection, in which the company's solutions include image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint the most prevalent cancers earlier, and a range of Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, in which the company provides the Xoft Axxent Electronic Brachytherapy (eBx) System, an isotope-free cancer treatment platform technology for treatment of early-stage breast cancer, and among others.
Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.